Skip to content
MARKETS / NASDAQ / NATR
NASDAQ · PHARMACEUTICAL PREPARATIONS · MID CAP

Natures Sunshine Products Inc. NATR

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$480.1M
▲ 5.7% YoY
$19.5M
▲ 153.7% YoY
$28.8M
▲ 101.3% YoY
In brief

What this company does

Nature's Sunshine Products, Inc. is engaged in the manufacturing and direct selling of nutritional and personal care products. It sells its products to a sales force of independent consultants who use the products themselves or resell them to consumers. It has four business segments, Asia, Europe, North America and Latin America and Other, based primarily upon the geographic region where each segment operates, and the geographic segments operate under the Nature's Sunshine Products and Synergy WorldWide brands. Its line of over 800 products includes several product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. Products sold in the United States are shipped directly from its manufacturing and warehouse facilities located in Spanish Fork, Utah, as well as from its regional warehouses located in Georgia, Ohio and Texas. As of December 31, 2025, it employed 806 individuals. Nature's Sunshine Products, Inc. is a Utah corporation formed in 1976 with its principal place of business in Lehi, Utah.

Written from the business description in NATURES SUNSHINE PRODUCTS INC's annual report to the U.S. Securities and Exchange Commission, filed 10 March 2026. Every sentence was checked against that document before publication.

Growth
USD 480.1M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 480.1 · Net income 19.5
200M400M200920112013201520172019202120232025
Compound annual growth
+4.4%
+4.5%
+4.0%
+2.1%
−0.2%
+3.2%
+6.3%
+4.7%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +4.5% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
4 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 5.2% · Net 4.3%
5%-2%-4%200920112013201520172019202120232025
ROE
FY2011 · ROE 22.6%
10%20%200920112013201520172019202120232025

Cash & shareholders
USD 16.3M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 28.8
20M-5M-10M200920112013201520172019202120232025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 16.3
20M40MDividendsNet buybacks20092013201520172020202220242025

USD 16.3M in buybacks — 84% of the year's profit went back to shareholders.

Total assetsUSD 261.1M
CashUSD 93.9M
Current ratio2.28×

Not available: we don't have the total debt figure for this period.

The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B0.50.50.40.40.40.40.40.40.30.30.30.40.40.40.40.30.3
Operating income $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
EBITDA $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Income tax $B0.00.00.00.00.0−0.00.00.00.00.00.0−0.00.00.00.00.00.0
Net income $B0.00.00.0−0.00.00.00.0−0.0−0.00.00.00.00.00.00.0−0.00.0
Free cash flow $B0.00.00.0−0.00.00.00.00.00.0−0.0−0.0−0.00.00.00.00.0−0.0
EPS, diluted $1.060.400.77−0.021.421.070.34−0.04−0.690.110.770.561.071.591.12−0.080.39
Dividend / sh $···0.001.000.000.000.000.100.400.401.901.900.15··0.05
Payout %···−0············13
ROE %··············22.6−2.010.7
Shares out B0.020.020.020.020.020.020.020.020.020.020.020.020.020.020.020.02·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 82 reconciliationsAUDITED

Reconciled in 17 of 19 fiscal years. 12 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPharmaceutical Preparations
Listed onNASDAQ
Incorporated inUtah
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2009

Share this section

Download image